VYNE Therapeutics (VYNE) Change in Cash (2017 - 2026)
VYNE Therapeutics (VYNE) posted Change in Cash of $604000.0 for Q1 2026, up 109.8% on a QoQ basis from -$6.2 million in Q2 2025, and down 92.71% year-over-year from $8.3 million in Q1 2025.
VYNE Therapeutics (VYNE) Change in Cash (2017 - 2026) Analysis & Trends
VYNE Therapeutics' Change in Cash history runs 10 years deep, the most recent figure standing at $604000.0 for Q1 2026.
- Quarterly Change in Cash fell 92.71% year-over-year to $604000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 30.34% YoY) and the FY2025 annual result came in at $4.1 million, up 138.16% from the prior year.
- Change in Cash was $604000.0 for Q1 2026 at VYNE Therapeutics, up from -$6.2 million in the prior quarter.
- Across five years, Change in Cash topped out at $15.2 million in Q4 2023 and bottomed at -$13.3 million in Q3 2024.
- A 5-year average of -$1.3 million and a median of -$4.6 million in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash soared 429.68% — and 2024, when it slumped 1562.59%.
- VYNE Therapeutics' Change in Cash stood at -$4.6 million in 2022, then surged by 429.68% to $15.2 million in 2023, then slumped by 76.23% to $3.6 million in 2024, then tumbled by 270.83% to -$6.2 million in 2025, then soared by 109.8% to $604000.0 in 2026.
- Business Quant data shows VYNE's Change in Cash at $604000.0 in Q1 2026, -$6.2 million in Q2 2025, and $8.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 57.19 Mn |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | 604,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 604,000.00 |
| Jun 30, 2025 | -6.16 Mn |
| Mar 31, 2025 | 8.28 Mn |
| Dec 31, 2024 | 3.61 Mn |
| Sep 30, 2024 | -13.34 Mn |
| Jun 30, 2024 | 10.54 Mn |
| Mar 31, 2024 | -11.56 Mn |
| Dec 31, 2023 | 15.17 Mn |
| Sep 30, 2023 | -5.20 Mn |
| Jun 30, 2023 | -9.58 Mn |
| Mar 31, 2023 | -695,000.00 |
| Dec 31, 2022 | -4.60 Mn |
| Sep 30, 2022 | -7.24 Mn |
| Jun 30, 2022 | -8.29 Mn |
| Mar 31, 2022 | 8.25 Mn |
| Dec 31, 2021 | -10.06 Mn |
| Sep 30, 2021 | -51.10 Mn |
| Jun 30, 2021 | -15.36 Mn |
| Mar 31, 2021 | 60.95 Mn |
| Dec 31, 2020 | -15.39 Mn |